A domain called the 'Conserved region in the middle' is responsible for target recognition in the TORC2 complex in fission yeast and the mTORC2 complex in mammals.
Cellular growth is a tightly regulated process that depends on the availability of energy and nutrients. Moreover, in multicellular species, the proliferation of cells must be coordinated across tissues and organs. Protein kinases called target of rapamycin (TOR) proteins and their mammalian ortholog mTOR have a central role in growth regulation. These proteins exert their function in two complexes called TORC1 and TORC2 (or mTORC1 and mTORC2 in mammals). These complexes act as regulatory hubs that integrate input signals concerning the availability of energy and nutrients or the presence of growth factors. With their outputs, the mTOR complexes control metabolism and protein biosynthesis, and influence cell cycle progression, autophagy and cytoskeletal organization (Laplante and Sabatini, 2012; Shimobayashi and Hall, 2014).
TOR and mTOR are very large proteins (containing approximately 2300–2600 amino acids) and are members of the PIKK family of regulatory kinases. Both mTOR complexes comprise mTOR and a protein called mLST8 (Figure 1A). mTORC1 also contains a protein called Raptor, whereas mTORC2 further includes the proteins Rictor and SIN1. In both complexes, the partner proteins of mTOR determine the target specificity of the mTOR kinase (Cameron et al., 2011; Nojima et al., 2003). mTORC1 phosphorylates a diverse set of targets involved in protein biosynthesis, metabolism and transcriptional regulation, while mTORC2’s most prominent targets are regulatory kinases of the AGC family.
In mTORC1, the Raptor N-terminal conserved (RNC) domain is known to be involved in the binding of linear recognition motifs in target proteins (Dunlop et al., 2009). Recent cryo-electron microscopy studies have provided a first glimpse at its function in mTORC1 (Aylett et al., 2016). The RNC domain is well positioned in the vicinity of the kinase active site to both recognize target motifs (Beugnet et al., 2003) and to sterically prevent – in cooperation with parts of mTOR – bulky non-target proteins accessing the kinase.
However, less is known about target recognition in TORC2 and mTORC2. Now, in eLife, researchers at the Nara Institute of Science and Technology, Osaka University and the University of California, Davis -- including Hisashi Tatebe and Shinichi Murayama as joint first authors, and Tatebe and Kazuhiro Shiozaki as corresponding authors -- report the results of a series of studies on human SIN1 and its fission yeast ortholog Sin1, that shed light on the conserved role of these proteins in target binding (Tatebe et al., 2017).
SIN1 and its orthologs are known to contain four domains (Figure 1B): a variable N-terminal region (Frias et al., 2006); the ‘Conserved region in the middle’ (CRIM); an RB domain; and a PH domain. However, the role of these domains in mTORC2 target recognition remained unclear, and structural data were only available for the isolated PH domain (Pan and Matsuura, 2012). Now Tatebe et al. have clearly shown that the CRIM domain has a key role in target recognition. In particular, they demonstrated that in fission yeast, the CRIM domain in Sin1 is primarily responsible for binding targets from the AGC kinase family. In human cell lines, the CRIM domain in SIN1 is at least involved in recognition of related targets, implying an evolutionary conserved role for this domain.
Based on earlier studies (Liu et al., 2015), SIN1 may even directly interact with the mTOR kinase domain in mTORC2. Thus, SIN1 might also be positioned to restrict access of the substrate to the kinase, eventually in cooperation with Rictor, similar to Raptor in mTORC1. Tatebe et al. also highlighted the crucial role of spatial proximity in target recognition by demonstrating that fusion of only the TORC2 target-binding CRIM domain into TORC1 is sufficient to let TORC1 phosphorylate a TORC2 substrate.
Tatebe et al. also report an NMR structure for the CRIM domain in fission yeast that reveals a ubiquitin-like fold with a prominent acidic loop. Mutational analysis confirms that target binding depends on the integrity of the CRIM domain and strongly suggests that the acidic loop is involved in binding.
With the functional role and structure of the CRIM domain now firmly established, researchers can start to address the many remaining questions about TORC2 target recognition. The NMR structure of the CRIM domain provides an excellent platform for a detailed analysis of the recognition of specific motifs in target substrates by SIN1. However, studies of the overall integration of SIN1 into mTORC2 will be required to address the consequences of SIN1-target binding for subsequent phosphorylation. Finally, work on target recognition in mTOR complexes together with recent structural and functional studies on other PIKK family kinases (Sibanda et al., 2017) may reveal the presence (or absence) of common principles in target recognition across the entire PIKK family.
mTORC2 targets AGC kinases through Sin1-dependent recruitmentBiochemical Journal 439:287–297.https://doi.org/10.1042/BJ20110678
PtdIns(3,4,5)P3-Dependent activation of the mTORC2 kinase complexCancer Discovery 5:1194–1209.https://doi.org/10.1158/2159-8290.CD-15-0460
The mammalian target of rapamycin (mTOR) partner, Raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motifJournal of Biological Chemistry 278:15461–15464.https://doi.org/10.1074/jbc.C200665200
Structures of the pleckstrin homology domain of Saccharomyces cerevisiae Avo1 and its human orthologue Sin1, an essential subunit of TOR complex 2Acta Crystallographica Section F Structural Biology and Crystallization Communications 68:386–392.https://doi.org/10.1107/S1744309112007178
Making new contacts: the mTOR network in metabolism and signalling crosstalkNature Reviews Molecular Cell Biology 15:155–162.https://doi.org/10.1038/nrm3757
Downloads (link to download the article as PDF)
Download citations (links to download the citations from this article in formats compatible with various reference manager tools)
Open citations (links to open the citations from this article in various online reference manager services)
The actin filament nucleator Arp2/3 complex is activated at cortical sites in Schizosaccharomyces pombe to assemble branched actin networks that drive endocytosis. Arp2/3 complex activators Wsp1 and Dip1 are required for proper actin assembly at endocytic sites, but how they coordinately control Arp2/3-mediated actin assembly is unknown. Alone, Dip1 activates Arp2/3 complex without preexisting actin filaments to nucleate ‘seed’ filaments that activate Wsp1-bound Arp2/3 complex, thereby initiating branched actin network assembly. In contrast, because Wsp1 requires preexisting filaments to activate, it has been assumed to function exclusively in propagating actin networks by stimulating branching from preexisting filaments. Here we show that Wsp1 is important not only for propagation but also for initiation of endocytic actin networks. Using single molecule total internal reflection fluorescence microscopy we show that Wsp1 synergizes with Dip1 to co-activate Arp2/3 complex. Synergistic co-activation does not require preexisting actin filaments, explaining how Wsp1 contributes to actin network initiation in cells.
The >800 human G protein–coupled receptors (GPCRs) are responsible for transducing diverse chemical stimuli to alter cell state- and are the largest class of drug targets. Their myriad structural conformations and various modes of signaling make it challenging to understand their structure and function. Here, we developed a platform to characterize large libraries of GPCR variants in human cell lines with a barcoded transcriptional reporter of G protein signal transduction. We tested 7800 of 7828 possible single amino acid substitutions to the beta-2 adrenergic receptor (β2AR) at four concentrations of the agonist isoproterenol. We identified residues specifically important for β2AR signaling, mutations in the human population that are potentially loss of function, and residues that modulate basal activity. Using unsupervised learning, we identify residues critical for signaling, including all major structural motifs and molecular interfaces. We also find a previously uncharacterized structural latch spanning the first two extracellular loops that is highly conserved across Class A GPCRs and is conformationally rigid in both the inactive and active states of the receptor. More broadly, by linking deep mutational scanning with engineered transcriptional reporters, we establish a generalizable method for exploring pharmacogenomics, structure and function across broad classes of drug receptors.